P

Inventor

VISNICK MELEAN

US52 patents
⚠️ This page may combine multiple inventors who share the name “VISNICK MELEAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REATA PHARMACEUTICALS INC

34 patents
US7915402B2Mar 29, 2011

Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring

REATA PHARMACEUTICALS INC105 citations99
US9102681B2Aug 11, 2015

Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17

REATA PHARMACEUTICALS INC31 citations98
US9090574B2Jul 28, 2015

Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring

REATA PHARMACEUTICALS INC30 citations98
USRE45325EJan 6, 2015

Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring

REATA PHARMACEUTICALS INC35 citations98
USRE45288EDec 9, 2014

Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring

REATA PHARMACEUTICALS INC34 citations98
US7943778B2May 17, 2011

Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives

REATA PHARMACEUTICALS INC89 citations97
US10556858B2Feb 11, 2020

Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17

REATA PHARMACEUTICALS INC13 citations94
US10398711B2Sep 3, 2019

C17-heteroaryl derivatives of oleanolic acid and methods of use thereof

REATA PHARMACEUTICALS INC15 citations94
US9889143B2Feb 13, 2018

C17-heteroaryl derivatives of oleanolic acid and methods of use thereof

REATA PHARMACEUTICALS INC19 citations94
US9670147B2Jun 6, 2017

Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17

REATA PHARMACEUTICALS INC21 citations94
US9278912B2Mar 8, 2016

C13-hydroxy derivatives of oleanolic acid and methods of use thereof

REATA PHARMACEUTICALS INC30 citations94
US10093614B2Oct 9, 2018

Antioxidant Inflamation modulators: oleanolic acid derivatives with amino and other modifications at C-17

REATA PHARMACEUTICALS INC14 citations93
US9556222B2Jan 31, 2017

A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof

REATA PHARMACEUTICALS INC21 citations93
US9249089B2Feb 2, 2016

Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives

REATA PHARMACEUTICALS INC30 citations93
US9884809B2Feb 6, 2018

Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators

REATA PHARMACEUTICALS INC11 citations92
US9593074B2Mar 14, 2017

C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof

REATA PHARMACEUTICALS INC17 citations92
US9512094B2Dec 6, 2016

C17-heteroaryl derivatives of oleanolic acid and methods of use thereof

REATA PHARMACEUTICALS INC22 citations92
US9174941B2Nov 3, 2015

Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators

REATA PHARMACEUTICALS INC22 citations92
US11091430B2Aug 17, 2021

Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17

REATA PHARMACEUTICALS INC4 citations84
US10501489B2Dec 10, 2019

C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof

REATA PHARMACEUTICALS INC12 citations84
US9796668B2Oct 24, 2017

Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use

REATA PHARMACEUTICALS INC12 citations83
US11406648B2Aug 9, 2022

C17-heteroaryl derivatives of oleanolic acid and methods of use thereof

REATA PHARMACEUTICALS INC1 citations73
US10898499B2Jan 26, 2021

C17-heteroaryl derivatives of oleanolic acid and methods of use thereof

REATA PHARMACEUTICALS INC2 citations73
US11192852B2Dec 7, 2021

Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators

REATA PHARMACEUTICALS INC2 citations72
US11292781B2Apr 5, 2022

Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other uses

REATA PHARMACEUTICALS INC4 citations70
US12595278B2Apr 7, 2026

Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway

REATA PHARMACEUTICALS INC0 citations62
US11827664B2Nov 28, 2023

Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway

REATA PHARMACEUTICALS INC1 citations62
US11814338B2Nov 14, 2023

Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators

REATA PHARMACEUTICALS INC0 citations62
US12545701B2Feb 10, 2026

C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses

REATA PHARMACEUTICALS INC0 citations61
US11584775B2Feb 21, 2023

C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses

REATA PHARMACEUTICALS INC0 citations61
US11059792B2Jul 13, 2021

Imidazolyl tricyclic enones as antioxidant inflammation modulators

REATA PHARMACEUTICALS INC1 citations61
US12344631B2Jul 1, 2025

C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof

REATA PHARMACEUTICALS INC0 citations59
US12195443B2Jan 14, 2025

Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other uses

REATA PHARMACEUTICALS INC0 citations59
US12060340B2Aug 13, 2024

Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith

REATA PHARMACEUTICALS INC0 citations52

ANDERSON ERIC

8 patents

JIANG XIN

3 patents

REATA PHARMACEUTICALS HOLDINGS LLC

2 patents

WARNER LAMBERT CO

2 patents

ABBVIE INC

1 patent

Showing the top 50 of 52 patents by PatentIndex Score.